Hirokuni Ikeda
Impact in
-
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Surgery 18
- Gastrointestinal disorders and treatments 6
- Pancreatitis Pathology and Treatment 3
- Trauma Management and Diagnosis 3
- Esophageal and GI Pathology 3
- Abdominal vascular conditions and treatments 3
-
- Metastasis and carcinoma case studies 3
- Co-authors
- Hiroyoshi Doihara (16 shared papers)Naruto Taira (15 shared papers)Tadahiko Shien (14 shared papers)Kensuke Kawasaki (4 shared papers)Yutaka Ogasawara (4 shared papers)Takeo Fujita (3 shared papers)Mina Takahashi (1 shared paper)Shinichi Toyooka (8 shared papers)
- Journals
- Breast Cancer (3 papers)Cancer Science (3 papers)Clinical Breast Cancer (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Cancer Research (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hirokuni Ikeda
33 papers receiving 466 citations
Peers
Comparison fields: 5 of 66
- Oncology 170
- Cancer Research 87
- Pulmonary and Respiratory Medicine 99
- Pathology and Forensic Medicine 49
- Molecular Biology 175
Countries citing papers authored by Hirokuni Ikeda
This map shows the geographic impact of Hirokuni Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokuni Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokuni Ikeda more than expected).
Fields of papers citing papers by Hirokuni Ikeda
This network shows the impact of papers produced by Hirokuni Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokuni Ikeda. The network helps show where Hirokuni Ikeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hirokuni Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 74 | |
| 2 | 2009 | 65 | |
| 3 | 2018 | 58 | |
| 4 | 2010 | 57 | |
| 5 | 2011 | 39 | |
| 6 | 2012 | 28 | |
| 7 | 2008 | 24 | |
| 8 | 2019 | 21 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 9 | |
| 11 | 2015 | 9 | |
| 12 | 2020 | 8 | |
| 13 | [A Case of Primary Acinic Cell Carcinoma(ACC)of the Breast]. | 2016 | 8 |
| 14 | 2003 | 7 | |
| 15 | 2015 | 6 | |
| 16 | 2016 | 5 | |
| 17 | 2007 | 5 | |
| 18 | 2013 | 5 | |
| 19 | 2013 | 4 | |
| 20 | 2019 | 3 |
About Hirokuni Ikeda
Hirokuni Ikeda is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Gastroenterology and Molecular Biology, having authored 44 papers that have together received 483 indexed citations. Recurring topics across this work include Gastrointestinal disorders and treatments (6 papers), Pancreatitis Pathology and Treatment (3 papers), Trauma Management and Diagnosis (3 papers), Esophageal and GI Pathology (3 papers), Abdominal vascular conditions and treatments (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Metastasis and carcinoma case studies (3 papers) and Foreign Body Medical Cases (2 papers). The work is most often cited by research in Oncology (170 citations), Cancer Research (87 citations), Pulmonary and Respiratory Medicine (99 citations), Pathology and Forensic Medicine (49 citations) and Molecular Biology (175 citations). Hirokuni Ikeda has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroyoshi Doihara, Naruto Taira, Tadahiko Shien, Kensuke Kawasaki, Yutaka Ogasawara, Takeo Fujita, Mina Takahashi, Shinichi Toyooka, Tomohiro Nogami and Shinichiro Miyoshi. Their work appears in journals such as Breast Cancer, Cancer Science, Clinical Breast Cancer, Cancer Chemotherapy and Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.